Search results
21 mar 2024 · The LoDoCo2 trial (Low-Dose Colchicine-2) and COLCOT (Colchicine Cardiovascular Outcomes Trial) demonstrated the efficacy of colchicine in lowering the risk of major adverse cardiovascular events in people with stable coronary artery disease (LoDoCo2) and recent myocardial infarction (COLCOT).
- Colchicine in Cardiovascular Disease: In-Depth Review
PPS should be differentiated from isolated pericardial or...
- Colchicine in Cardiovascular Disease: In-Depth Review
29 gru 2021 · PPS should be differentiated from isolated pericardial or pleural effusion seen after cardiac surgery, and specific diagnostic criteria exist. 40 Colchicine should be considered for PPS treatment according to ESC guidelines (class IIa recommendation, level of evidence B) using the pericarditis treatment regimens. 6 The role of colchicine in the ...
31 sie 2020 · Methods. In a randomized, controlled, double-blind trial, we assigned patients with chronic coronary disease to receive 0.5 mg of colchicine once daily or matching placebo. The primary end...
4 cze 2024 · Patients presenting with acute HF, clinical evidence of congestion requiring ≥40 mg of intravenous furosemide and N-terminal pro-B-type natriuretic peptide (NT-proBNP) >900 pg/ml, are eligible for participation.
Colchicine is an old anti-inflammatory drug that has shown substantial cardiovascular benefits in recent trials. We systematically reviewed cardiovascular benefits and harms of colchicine in any population and specifically in patients with high cardiovascular risk.
Our trial was designed to investigate if the treatment with colchicine (1) decreases systemic low-grade inflammation in HFpEF and reduces inflammation-related biomarker of HF sST2 and marker of systemic inflammation hsCRP, and (2) influences left ventricular diastolic function and remodelling.
Generic Name (S): colchicine (cardiac) Uses. Side Effects. Precautions. Interactions. Overdose. Images. Reviews (0) Uses. Colchicine is used by people with heart disease or people who...
